Tumor Detection Using Iodine-131-Labeled Monoclonal Antibody 8H9
NCT00582608
·
clinicaltrials.gov ↗
NA
Phase
TERMINATED
Status
12
Enrollment
OTHER
Sponsor class
Stopped
Lack of accrual
Conditions
CNS Cancer
Neuroblastoma
Sarcoma
Interventions
DRUG:
131I-8H9
DRUG:
8H9
Sponsor
Memorial Sloan Kettering Cancer Center